Patent ID: 9585877
Date: 2017-03-07
CPC Classifications: A61K,A61P

Claim:
1. A method of treating a patient having a cognitive impairment, comprising: administering to the patient, for an extended period of at least 12 weeks, a daily dose of a pharmaceutical composition comprising (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide, or a pharmaceutically acceptable salt thereof; wherein the cognitive impairment is limited cognitive impairment (LCI), mild cognitive impairment (MCI), Alzheimer's disease, or dementia of the Alzheimer's-type; wherein the patient has scored a sub-normal value on one or more cognitive assessment tests, comprising: MMSE, ADAS-Cog-13, ADAS-Cog-11, COWAT, CFT, or CDR-SB.